Health state utilities for beta-thalassemia: a time trade-off study

Grazzi, EF, Chevali, M, Mighiu, C and Martin, Antony ORCID: 0000-0003-4383-6038 (2023) Health state utilities for beta-thalassemia: a time trade-off study. In: EHA, Germany.

Text Abstract EHA TTO.docx - Published Version Download (74kB)

Abstract

<h4>Background</h4>Beta-thalassemia (BT) is an inherited blood disorder characterized by reduced levels of functional hemoglobin resulting in phenotypes ranging from clinically asymptomatic to severely anemic. Patients with BT may require lifelong regular blood transfusions supported by appropriate iron chelation therapy (ICT). This study aimed to determine how the UK general population values BT health states associated with differing transfusion burden and ICT.<h4>Methods</h4>Composite time trade-off (cTTO) methodology was employed to elicit health state utilities in BT. Relevant BT literature related to symptom and quality-of-life impact, including physical, functional, and emotional well-being, and safety profiles of BT treatments were considered when drafting health state descriptions. Eleven health state descriptions were developed and validated by hematologists and patient advocates for clinical accuracy and completeness. 200 individuals from the UK general population participated in the cTTO interviews.<h4>Results</h4>The mean age of participants was 41.50 years (SD 16.01, range 18-81); 88 (46.8%) were female. Utility values ranged from 0.78 (SD 0.34) for non-transfusion dependent BT with oral ICT to 0.37 (SD 0.50) for high transfusion burden with subcutaneous ICT in transfusion-dependent BT.<h4>Conclusions</h4>This study provides health utilities for a range of BT health states from the UK general population perspective. Importantly, lower transfusion burden and lower burden of anemia were associated with higher utilities. To a lesser extent, differential modes of ICT were found to impact utility valuations in patients with BT. The utilities obtained in this study can be employed as inputs in cost-effectiveness analyses of BT therapies.

Item Type:	Conference or Workshop Item (Unspecified)
Uncontrolled Keywords:	Beta-thalassemia, Hemoglobin, Anemia, Time trade-off, Transfusion burden
Depositing User:	Symplectic Admin
Date Deposited:	03 Nov 2020 09:54
Last Modified:	22 Feb 2023 11:00
DOI:	10.1007/s10198-022-01449-7
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3105841